Alcon AG (ALC)
Alcon AG (ALC) carries a ŷRobot AI score of 67 out of 100. The model's fair value estimate is $77.36, 4.4% above the last close of $74.13. The chart signal reads Bearish.
| Metric | ALC |
|---|---|
| AI score | 67 / 100 |
| Chart signal | Bearish |
| Fair value estimate | $77.36 |
| Upside to fair value | 4.4% |
| Previous close | $74.13 |
| P/E | 52.89 |
| Price / sales | 3.19 |
| Market cap | $35.03B |
| EPS | 1.37 |
| Revenue growth | 5.7% |
| 1-year price change | 3.1% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, Merck & Company Inc, UnitedHealth Group Incorporated, Novartis AG ADR.
Questions about ALC
Is ALC overvalued or undervalued right now?
As of Nov 12, 2026, ŷRobot's fair-value model estimates Alcon AG (ALC) at $77.36 against a last close of $74.13, implying 4.4% upside to the model's estimate.
Is ALC's chart signal bullish or bearish?
The chart-signal model classifies ALC as Neutral as of Nov 13, 2026, with a signal score of -0.10 on a -1 to 1 scale.
What is ALC's ŷRobot AI score?
ALC scores 67 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Nov 13, 2026.
Is ALC stock expensive on P/E and P/S?
ALC trades at 52.9 times earnings and 3.2 times sales as of Nov 13, 2026.
What does ALC's seasonal forecast show?
ŷRobot's seasonal forecast curve for ALC reads +0.9% at 30 days, +5.7% at 90 days, and +3.1% at one year as of Nov 13, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is ALC growing?
Alcon AG's revenue growth is +5.7% and free-cash-flow growth is +4.5% on the latest reported figures.
ALC chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.